Shinil Pharmaceutical
신일제약 · 012790
Health Care Pharmaceuticals · KOSDAQ
Market cap US$44.9M (₩62B)
Overview
Shinil Pharmaceutical makes a wide range of medicines, including tablets, capsules, syrups, ointments, creams, injectables, and patches, and supplies them to hospitals and other medical institutions.
The company also manufactures medicines on behalf of other pharmaceutical companies, a service known as contract manufacturing (CMO). In addition, it operates a consumer brand called 'Farmtree' that offers functional cosmetics and health-supplement foods developed using its pharmaceutical expertise. It is listed on KOSDAQ, South Korea's tech and small-cap stock exchange.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$64.6M
- FY2024US$64.8M
- FY2025US$58.4M
Operating profit
- FY2023US$10.1M
- FY2024US$11M
- FY2025US$5.4M
Net income
- FY2023US$9.9M
- FY2024US$10.4M
- FY2025US$5.5M
Key ratios (FY2025)
Why it matters
Beyond its own branded medicines, Shinil runs a contract manufacturing business serving other pharmaceutical companies, giving it a second revenue stream tied to the broader Korean pharma industry.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?